LWMI
DNA icon

Legacy Wealth Management (Idaho)’s Ginkgo Bioworks DNA Stock Holding History

Legacy Wealth Management (Idaho)’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$687 Hold
112
– – ﹤0.01% 913
2025
Q4 		$931 Hold
112
– – ﹤0.01% 757
2025
Q3 		$1.63K Hold
112
– – ﹤0.01% 564
2025
Q2 		$1.26K Hold
112
– – ﹤0.01% 569
2025
Q1 		$639 Hold
112
– – ﹤0.01% 680
2024
Q4 		$1.6K Sell
112
-38
-25% -$326 ﹤0.01% 534
2024
Q3 		$1.29K Buy
+150
New +$1.5K ﹤0.01% 522

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legacy Wealth Management (Idaho)'s DNA Position: Q1 2026 in Review

Legacy Wealth Management (Idaho) held its Ginkgo Bioworks (DNA) position steady in Q1 2026 at 112 shares worth $687. The position accounts for ﹤0.01% of the portfolio, ranked #913.

Legacy Wealth Management (Idaho) first reported a position in DNA in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.63K in Q3 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Legacy Wealth Management (Idaho) held 112 shares of Ginkgo Bioworks worth $687 as of Q1 2026.
  • Legacy Wealth Management (Idaho) left its Ginkgo Bioworks share count unchanged in Q1 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Legacy Wealth Management (Idaho)'s portfolio in Q1 2026, its #913 holding.
  • Legacy Wealth Management (Idaho) first reported a position in Ginkgo Bioworks in Q3 2024 and has held it in 7 quarters since.
  • Legacy Wealth Management (Idaho)'s Ginkgo Bioworks position peaked at $1.63K in Q3 2025.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q1 2026, filed 7 May 2026.